UK Medical Group Rejects New Skin Cancer Treatment

[Valin]

ABC/AP:

MARIA CHENG AP Medical Writer
LONDON October 14, 2011

An independent British medical watchdog says the first treatment proven to help people with the deadliest form of skin cancer is too expensive to be used by the U.K.'s health care system, a recommendation critics called a potential death sentence.

The drug, Bristol-Myers Squibb's Yervoy, has offered some hope to people with advanced skin cancers, though a study of patients with advanced, inoperable melanoma showed it extended survival only four months on average.
(Snip)

It's 4 months of life so who cares.